In its office order dated 31 March 2016, the Indian Patent Office has stated that an auto-allotment system for allotting patent applications to examiners will be implemented. The order further states that FERs for patent applications will be sent to the applicants or their agents through e-mail only. For more information, please check here.

US Patent Office granted BioCatch a new patent which detects user identities on electronic devices. The patent outlines a method of detecting a user based on a motor-control loop model. [More]

Winchester native and inventor Dale E. Van Cor’s newly patented nuts and bolts can now be manufactured right in town at Innovative Machine. This can be achieved through software which would be helpful in threading the nuts and bolts. [More]

Filing of further divisional applications is creating ambiguity with respect to a patent application is what the Mumbai Patent office says. [More]

Doctors without Borders has challenged Pfizer’s application for an Indian patent for its pneumonia vaccine so cheaper versions can be available to children in poor countries and to humanitarian organizations. [More]

MediciNova has received a Notice of Allowance from the U.S. Patent and Trademark Office for a pending patent application which covers MN-166 (Ibudilast) for the treatment of amyotrophic lateral sclerosis (ALS).[More]

Nano pore sequencing an inexpensive and portable approach to DNA has sparked a legal battle between Illumina, Inc.—which dominates the genetic sequencing industry—sued Oxford Nano pore Technologies, the first company to market a commercial Nano pore platform. [More]

Samsung Electronics has acquired a large number of graphene patents with more than 490 followed by China’s Ocean’s King Lighting Science & Technology and IBM Corp. Based on the naming of graphene as skinniest and strong material known, researchers believe its future use to make unbreakable screens for mobile devices [more].

Hepatitis C patients have been protesting for past one week outside India’s patent office in Dwarka against Gilead Sciences and the United States government for forcing the Indian government “to blindly and speedily grant patents”. IPO is in the process of hearing the company’s patent claim on the drug Sovaldi, with an astounding price of $84,000 (about Rs.57...

Researchers from the US Army Armament, Research, Development and Engineering center have lately patented a novel type of bullet, which unlike others is specially designed for self destruction after traveling for a definite distance [more].